Cargando…
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT
Allogeneic transplantation (allo-HCT) is a curative treatment in CLL whose efficacy including the most severe forms had led to the 2006 EBMT recommendations. The advent after 2014 of targeted therapies has revolutionized CLL management, allowing prolonged control to patients who have failed immunoch...
Autores principales: | Tournilhac, Olivier, van Gelder, Michel, Eikema, Dirk-Jan, Zinger, Nienke, Dreger, Peter, Bornhäuser, Martin, Vucinic, Vladan, Scheid, Christof, Cornelissen, Jan J., Schroeder, Thomas, Jindra, Pavel, Sengeloev, Henrik, Nguyen Quoc, Stephanie, Stelljes, Matthias, Blau, Igor Wolfgang, Mayer, Jiri, Paneesha, Shankara, Chevallier, Patrice, Forcade, Edouard, Kröger, Nicolaus, Blaise, Didier, Gribben, John, Nielsen, Bendt, Johansson, Jan-Erik, Kyriakou, Charalampia, Beguin, Yves, Pioltelli, Pietro, Sampol, Antònia, McLornan, Donal P., Schetelig, Johannes, Hayden, Patrick J., Yakoub-Agha, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044103/ https://www.ncbi.nlm.nih.gov/pubmed/36977926 http://dx.doi.org/10.1038/s41409-023-01955-z |
Ejemplares similares
-
Allogeneic hematopoietic cell transplant for hairy cell leukemia: EBMT experience
por: Chihara, Dai, et al.
Publicado: (2022) -
Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT
por: Robin, Marie, et al.
Publicado: (2023) -
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
por: Gagelmann, Nico, et al.
Publicado: (2019) -
Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party
por: Schetelig, Johannes, et al.
Publicado: (2020) -
Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party
por: Schetelig, Johannes, et al.
Publicado: (2021)